A Multicenter, Randomized Controlled Trial of Cerebrospinal Fluid Drainage in Acute Spinal Cord Injury
Abstract
The purpose of this randomized clinical trial is to evaluate the safety and efficacy of cerebrospinal fluid drainage (CSFD) and to provide a preliminary clinical efficacy evaluation of the combination of CSFD and elevation of mean arterial pressure (MAP) inpatients with acute spinal cord injury. This study is currently screening and enrolling patients at all three active centers, which include: Barrow Neurological Institute/Dignity Health (the main study site) in Arizona, the University of Arizona in Tucson and the University of Alabama in Birmingham. Steps have been initiated to add a high-volume spinal cord injury site from the East Coast to help drive the recruitment efforts which have jeopardized the project timelines. An Investigator Meeting is taking place in Q4 2017 to discuss barriers to recruitment and potential solutions.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2017
- Accession Number
- AD1043144
Entities
People
- Nicholas Theodore
- Veljko Kopjar
Organizations
- Dignity Health